Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-24 @ 1:17 PM
NCT ID:
NCT05726695
Eligibility Criteria:
Inclusion criteria (patient group):
* left ventricle ejection fraction (EF LV) equal or less than 40%
* age between 18-80 years
Inclusion criteria (control group):
* normal EF LV (left ventricular ejection fraction)
* no structural cardiac abnormalities
* age between 18-80 years.
Exclusion criteria:
* recent myocardial infarction
* recent percutaneous coronary intervention (PCI)
* recent decompensation of chronic heart failure
* chronic kidney disease with need for haemodialysis
* creatin level over 450 umol/l
* signs of acute or chronic inflammation with CRP (C-reactive protein) over 20 mg/l
* patient with a known tumour
* history of cardiovascular disease
* diabetes mellitus
* severe liver and kidney disease
* BNP (brain natriuretic peptide) \> 250 pg/ml or NTproBNP \> 500 pg/ml for males and 750 pg/ml for females
* signs of acute or chronic inflammation with CRP over 20 mg/l
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT05726695
Study Brief:
Protocol Section:
NCT05726695